The American Diabetes Association has announced six grants totaling more than $9.75 million to spur breakthroughs in diabetes science, care, and potential cures.
Awarded through the Pathway to Stop Diabetes program, the grants include support for postdoctoral fellows who are transitioning from training to research, diabetes researchers early in their independent careers, and scientists established in another field who are interested in applying their expertise to diabetes research for the first time. Each of the six 2017 Pathway scientists will receive $1.62 million over five to seven years. The recipients include Jonathan N. Flak of the University of Michigan; Aleksandar David Kostic of the Joslin Diabetes Center; Paul Cohen of Rockefeller University; Sarah A. Stanley of the Icahn School of Medicine at Mount Sinai; Sumita Pennathur of the University of California, Santa Barbara; and David A. Spiegel of Yale University School of Medicine.
"Pathway to Stop Diabetes is a unique program in the fight against diabetes. The Pathway program provides exceptional researchers with multiyear grants that allow them to follow the science where it leads them," said C. Ronald Kahn, chair of ADF's Mentor Advisory Group. "We are excited to build upon the already remarkable portfolio of individuals and research from our previous Pathway awardees. The substantial level of research support and flexibility enabled by Pathway provide opportunities to locate the hidden clues that can lead to innovative advancements that could improve outcomes for millions of people with diabetes, prediabetes, and diabetes complications."